Cargando…

Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron

In this report, we mechanistically reveal how the Variant of Concern (VOC) SARS-CoV-2 Omicron (B.1.1.529) escapes neutralizing antibody responses, by physio-chemical characterization of this variant in comparison to the wild-type Wuhan and the Delta variant (B.1.617.2). Convalescent sera, as well as...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogt, Anne-Cathrine S., Augusto, Gilles, Martina, Byron, Chang, Xinyue, Nasrallah, Gheyath, Speiser, Daniel E., Vogel, Monique, Bachmann, Martin F., Mohsen, Mona O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147318/
https://www.ncbi.nlm.nih.gov/pubmed/35632499
http://dx.doi.org/10.3390/vaccines10050743
_version_ 1784716777968631808
author Vogt, Anne-Cathrine S.
Augusto, Gilles
Martina, Byron
Chang, Xinyue
Nasrallah, Gheyath
Speiser, Daniel E.
Vogel, Monique
Bachmann, Martin F.
Mohsen, Mona O.
author_facet Vogt, Anne-Cathrine S.
Augusto, Gilles
Martina, Byron
Chang, Xinyue
Nasrallah, Gheyath
Speiser, Daniel E.
Vogel, Monique
Bachmann, Martin F.
Mohsen, Mona O.
author_sort Vogt, Anne-Cathrine S.
collection PubMed
description In this report, we mechanistically reveal how the Variant of Concern (VOC) SARS-CoV-2 Omicron (B.1.1.529) escapes neutralizing antibody responses, by physio-chemical characterization of this variant in comparison to the wild-type Wuhan and the Delta variant (B.1.617.2). Convalescent sera, as well as sera obtained from participants who received two or three doses of mRNA vaccines (Moderna-mRNA-1273(®) or Pfizer-BNT162b2(®)), were used for comparison in this study. Our data demonstrate that both Delta, as well as Omicron variants, exhibit a higher affinity for the receptor ACE2, facilitating infection and causing antibody escape by receptor affinity (affinity escape), due to the reduced ability of antibodies to compete with RBD-receptor interaction and virus neutralization. In contrast, only Omicron but not the Delta variant escaped antibody recognition, most likely because only Omicron exhibits the mutation at E484A, a position associated with reduced recognition, resulting in further reduced neutralization (specificity escape). Nevertheless, the immunizations with RNA-based vaccines resulted in marked viral neutralization in vitro for all strains, compatible with the fact that Omicron is still largely susceptible to vaccination-induced antibodies, despite affinity- and specificity escape.
format Online
Article
Text
id pubmed-9147318
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91473182022-05-29 Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron Vogt, Anne-Cathrine S. Augusto, Gilles Martina, Byron Chang, Xinyue Nasrallah, Gheyath Speiser, Daniel E. Vogel, Monique Bachmann, Martin F. Mohsen, Mona O. Vaccines (Basel) Article In this report, we mechanistically reveal how the Variant of Concern (VOC) SARS-CoV-2 Omicron (B.1.1.529) escapes neutralizing antibody responses, by physio-chemical characterization of this variant in comparison to the wild-type Wuhan and the Delta variant (B.1.617.2). Convalescent sera, as well as sera obtained from participants who received two or three doses of mRNA vaccines (Moderna-mRNA-1273(®) or Pfizer-BNT162b2(®)), were used for comparison in this study. Our data demonstrate that both Delta, as well as Omicron variants, exhibit a higher affinity for the receptor ACE2, facilitating infection and causing antibody escape by receptor affinity (affinity escape), due to the reduced ability of antibodies to compete with RBD-receptor interaction and virus neutralization. In contrast, only Omicron but not the Delta variant escaped antibody recognition, most likely because only Omicron exhibits the mutation at E484A, a position associated with reduced recognition, resulting in further reduced neutralization (specificity escape). Nevertheless, the immunizations with RNA-based vaccines resulted in marked viral neutralization in vitro for all strains, compatible with the fact that Omicron is still largely susceptible to vaccination-induced antibodies, despite affinity- and specificity escape. MDPI 2022-05-09 /pmc/articles/PMC9147318/ /pubmed/35632499 http://dx.doi.org/10.3390/vaccines10050743 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Vogt, Anne-Cathrine S.
Augusto, Gilles
Martina, Byron
Chang, Xinyue
Nasrallah, Gheyath
Speiser, Daniel E.
Vogel, Monique
Bachmann, Martin F.
Mohsen, Mona O.
Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron
title Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron
title_full Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron
title_fullStr Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron
title_full_unstemmed Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron
title_short Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron
title_sort increased receptor affinity and reduced recognition by specific antibodies contribute to immune escape of sars-cov-2 variant omicron
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147318/
https://www.ncbi.nlm.nih.gov/pubmed/35632499
http://dx.doi.org/10.3390/vaccines10050743
work_keys_str_mv AT vogtannecathrines increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron
AT augustogilles increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron
AT martinabyron increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron
AT changxinyue increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron
AT nasrallahgheyath increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron
AT speiserdaniele increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron
AT vogelmonique increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron
AT bachmannmartinf increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron
AT mohsenmonao increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron